Zhen Cheng Selected Research

Integrin alphaVbeta3

2/2010	Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin.
1/2006	Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
10/2005	microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen Cheng Research Topics

Disease

174	Neoplasms (Cancer) 05/2024 - 02/2002
21	Melanoma (Melanoma, Malignant) 12/2022 - 02/2002
12	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2005
10	Neoplasm Metastasis (Metastasis) 05/2024 - 10/2005
10	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2007
9	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 07/2012
9	Glioma (Gliomas) 11/2023 - 10/2005
9	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2012
8	Inflammation (Inflammations) 01/2021 - 01/2012
7	Carcinogenesis 01/2022 - 01/2011
6	Glomerulonephritis 10/2023 - 09/2016
5	Liver Neoplasms (Liver Cancer) 10/2022 - 03/2014
5	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2012
5	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 04/2014
4	Rupture 11/2023 - 06/2015
4	Osteoporosis 07/2023 - 01/2018
4	Atherosclerosis 01/2022 - 01/2012
4	Lung Neoplasms (Lung Cancer) 08/2019 - 02/2012
3	Infections 01/2024 - 12/2006
3	Pulmonary Embolism 12/2023 - 01/2021
3	Hypoxia (Hypoxemia) 12/2022 - 01/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2018
3	IGA Glomerulonephritis (IGA Nephropathy) 05/2020 - 12/2017
3	Myocardial Infarction 01/2020 - 01/2014
3	Disease Progression 01/2020 - 01/2016
3	Carcinoma (Carcinomatosis) 10/2019 - 06/2012
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 12/2016
3	Stroke (Strokes) 01/2018 - 06/2015

Drug/Important Bio-Agent (IBA)

49	Peptides (Polypeptides)IBA 08/2023 - 02/2002
28	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2008
28	IntegrinsIBA 10/2019 - 10/2005
21	Molecular Probes (Molecular Probe)IBA 12/2022 - 05/2005
20	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2008
17	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 05/2024 - 02/2002
15	Radioisotopes (Radionuclides)IBA 01/2023 - 02/2002
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2009
12	Coloring Agents (Dyes)IBA 12/2022 - 05/2010
12	Melanins (Melanin)IBA 12/2022 - 10/2009
10	Cystine-Knot MiniproteinsIBA 10/2019 - 03/2009
9	Contrast MediaIBA 01/2022 - 01/2011
9	arginyl-glycyl-aspartic acidIBA 11/2014 - 10/2005
8	Cystine (L-Cystine)IBA 10/2019 - 02/2010
7	Type 1 Melanocortin ReceptorIBA 12/2022 - 05/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2006
6	Therapeutic UsesIBA 10/2022 - 06/2014
6	IronIBA 01/2022 - 02/2011
6	EnzymesIBA 10/2020 - 06/2011
6	GoldIBA 10/2020 - 04/2013
6	CY5.5 cyanine dyeIBA 01/2020 - 05/2006
6	LigandsIBA 01/2019 - 07/2013
6	Bombesin Receptors (Bombesin Receptor)IBA 01/2018 - 06/2012
6	MetalsIBA 01/2017 - 02/2002
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 04/2016
5	Fluorescent Dyes (Fluorescent Probes)IBA 12/2022 - 11/2005
5	AcidsIBA 01/2018 - 03/2009
5	Indicators and Reagents (Reagents)IBA 10/2016 - 10/2005
5	RheniumIBA 12/2010 - 02/2002
5	alpha-MSHIBA 11/2009 - 02/2002
4	CytokinesIBA 01/2024 - 11/2011
4	Tumor Biomarkers (Tumor Markers)IBA 10/2023 - 05/2008
4	CreatinineIBA 10/2022 - 09/2012
4	Arginine (L-Arginine)FDA Link 10/2020 - 04/2010
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2020 - 09/2011
4	Monoclonal AntibodiesIBA 01/2020 - 08/2014
4	Chelating AgentsIBA 01/2017 - 06/2011
4	PeptidomimeticsIBA 01/2012 - 12/2009
3	Rituximab (Mabthera)FDA Link 04/2024 - 10/2022
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2015
3	Transcription Factors (Transcription Factor)IBA 07/2023 - 02/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 10/2020
3	AlbuminsIBA 12/2022 - 03/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2022 - 10/2008
3	AntibodiesIBA 07/2022 - 10/2008
3	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2018
3	IonsIBA 01/2022 - 09/2015
3	Immunoglobulin A (IgA)IBA 01/2021 - 12/2017
3	AntigensIBA 01/2021 - 04/2014
3	Human Serum Albumin FDA LinkGeneric 01/2020 - 01/2012
3	AminesIBA 08/2019 - 06/2005
3	Testosterone (Sustanon)FDA Link 01/2019 - 12/2016
3	Urokinase Plasminogen Activator ReceptorsIBA 11/2018 - 07/2013
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2017 - 11/2015
3	CathepsinsIBA 10/2016 - 01/2011
3	Cysteine (L-Cysteine)FDA Link 10/2016 - 01/2011
3	Aspartic Acid (Aspartate)FDA Link 01/2016 - 04/2010
3	Thymidine KinaseIBA 06/2014 - 01/2006
3	Firefly LuciferasesIBA 06/2014 - 05/2007

Therapy/Procedure

69	Therapeutics 04/2024 - 10/2005
20	Precision Medicine 05/2024 - 05/2014
11	Computer-Assisted Surgery (Image Guided Surgery) 04/2024 - 05/2017
9	Drug Therapy (Chemotherapy) 10/2022 - 02/2012
9	Quantum Dots (Quantum Dot) 09/2018 - 09/2008
8	Photothermal Therapy 12/2022 - 03/2014
6	Immunotherapy 01/2022 - 05/2016
5	Transplantation 01/2022 - 12/2006
5	Lasers (Laser) 01/2018 - 11/2012
4	Intravenous Injections 11/2023 - 01/2006
4	Radiotherapy 10/2022 - 02/2002
4	Photochemotherapy (Photodynamic Therapy) 04/2017 - 03/2014
3	Ligation 01/2020 - 06/2015